Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Title Grant Type Focus Area Country Application Due Date Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disordersRelease Date:Education Rare Disease Japan Long-acting Growth Hormone ResearchRelease Date:Research Rare Disease All COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)Release Date:Quality Improvement Oncology All 2020 Osteoarthritis and Osteoarthritis Pain- Virtual LearningEducation Internal Medicine All NASH – Future of Non-invasive Diagnosis TechnologiesRelease Date:Education Internal Medicine All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse NavigatorRelease Date:Quality Improvement Rare Disease USA Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)Release Date:Partner:International Society for Infectious Diseases (ISID)
Quality Improvement Hospital All Advances in Oncology Therapy in Renal Cell CarcinomaRelease Date:Education Oncology Japan Increasing Awareness of Nuclear Scintigraphy in Cardiac AmyloidosisRelease Date:Education Rare Disease All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China RegionRelease Date:Partner:RCNi (subsidiary of the Royal College of Nursing)
Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin AmericaRelease Date:Research Rare Disease Argentina, Brazil, Chile, Colombia Vaccine Preventable Diseases – COVID-19 (closed early)Release Date:Research Vaccines All